DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1

Oncogene

Volumn 24, Issue 48, 2005, Pages 7135-7144

  Hamdi, Mohamed ^a   Kool, Jaap ^a,c   Cornelissen Steijger, Paulien ^a   Carlotti, Francoise ^a   Popeijus, Herman E ^a   Van Der Burgt, Corina ^a   Janssen, Josephine M ^a   Yasui, Akira ^b   Hoeben, Rob C ^a   Terleth, Carrol ^a   Mullenders, Leon H ^a   Van Dam, Hans ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TOHOKU UNIVERSITY   (Japan)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

AP 1; DNA damage; JNK; MKP 1; Transcription coupled repair

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYCLOBUTANE; DEOXYRIBODIPYRIMIDINE PHOTOLYASE; DIMER; DNA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN P53; PYRIMIDINE; RNA POLYMERASE II; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; COCKAYNE SYNDROME; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DNA TRANSCRIPTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; SKIN FIBROBLAST; ULTRAVIOLET IRRADIATION; XERODERMA PIGMENTOSUM;

APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; COCKAYNE SYNDROME; DNA DAMAGE; DNA REPAIR; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMEDIATE-EARLY PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 27944469638     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208875     Document Type: Article

References (75)

1. Abrahams PJ, Houweling A, Cornelissen-Steijger PDM, Jaspers NGJ, Darroudi F, Meijers CM, Mullenders LHF, Filon R, Arwert F, Pinedo HM, Natarajan APT, Terleth C, van Zeeland AA and van der Eb AJ. (1998). Mut. Res-DNA Repair, 407, 189-201.
2. Abrahams PJ, Houweling A and van der Eb AJ. (1992). Cancer Res., 52, 53-57.
3. Abrahams PJ, van der Kleij AAM, Schouten R and van der Eb AJ. (1988). Cancer Res., 48, 6054-6057.
4. Alessi DR, Smythe C and Keyse SM. (1993). Oncogene, 8, 2015-2020.
5. Bazuine M, Carlotti F, Tafrechi RSJ, Hoeben RC and Maassen JA. (2004). Mol. Endocrinol., 18, 1697-1707.
6. Behrens A, Sibilia M and Wagner EF. (1999). Nat. Genet., 21, 326-329.
7. Berneburg M and Lehmann AR. (2001). Adv. Genet., 43, 71-102.
8. Blattner C, Bender K, Herrlich P and Rahmsdorf HJ. (1998). Oncogene, 16, 2827-2834.
9. Blattner C, Kannouche P, Litfin M, Bender K, Rahmsdorf HJ, Angulo JF and Herrlich P. (2000). Mol. Cell. Biol., 20, 3616-3625.
10. Bossy-Wetzel E, Bakiri L and Yaniv M. (1997). EMBO J., 16, 1695-1709.
11. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell RA and Davis RJ. (2003). Genes Dev., 17, 1969-1978.
12. Camps M, Nichols A and Arkinstall S. (2000). FASEB J., 14, 6-16.
13. Carlotti F, Bazuine M, Kekarainen T, Seppen J, Pognonec P, Maassen JA and Hoeben RC. (2004). Mol. Ther., 9, 209-217.
14. Chang LF and Karin M. (2001). Nature, 410, 37-40.
15. Davis RJ. (2000). Cell, 103, 239-252.
16. de Boer J and Hoeijmakers JHJ. (2000). Carcinogenesis, 21, 453-460.
17. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Caron M, Atfi A, Cherqui G and Capeau J. (2000). Endocrinology, 141, 922-931.
18. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS and Hulley PA. (2003). Endocrinology, 144, 412-422.
19. Farooq A and Zhou MM. (2004). Cell. Signal., 16, 769-779.
20. Ford JM and Hanawalt PC. (1995). Proc. Natl. Acad. Sci. USA, 92, 8876-8880.
21. Franklin CC and Kraft AS. (1997). J. Biol. Chem., 272, 16917-16923.
22. Franklin CC, Srikanth S and Kraft AS. (1998). Proc. Natl. Acad. Sci. USA, 95, 3014-3019.
23. Guo YL, Kang BB and Williamson JR. (1998). J. Biol. Chem., 273, 10362-10366.
24. Hai T, Wolfgang CD, Marsee DK, Allen AE and Sivaprasad U. (1999). Gene Expression, 7, 321-335.
25. Hayakawa J, Depatie C, Ohmichi M and Mercola D. (2003). J. Biol. Chem., 278, 20582-20592.
26. Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C, Omichi M, McClelland M and Mercola D. (2004). Mol. Cell, 16, 521-535.
27. Herrlich P, Bender K, Knebel A, Bohmer FD, Gross S, Blattner C, Rahmsdorf HJ and Gottlicher M. (1999). CR Acad. Sci. III, 322, 121-125.
28. Jaspers NGJ, Raams A, Kelner MJ, Ng JMY, Yamashita YM, Takeda S, McMorris TC and Hoeijmakers JHJ. (2002). DNA Repair, 1, 1027-1038.
29. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E and Givol D. (2001). Oncogene, 20, 2225-2234.
30. Keyse SM. (2000). Curr. Opin. Cell Biol., 12, 186-192.
31. Keyse SM and Emslie EA. (1992). Nature, 359, 644-647.
32. Kool J, Hamdi M, Cornelissen-Steijger PDM, van der Eb AJ, Terleth C and van Dam H. (2003). Oncogene, 22, 4235-4242.
33. Klein B, Pastink A, Odijk H, Westerveld A and van der Eb AJ. (1990). Exp. Cell Res., 191, 256-262.
34. Lamb JA, Ventura JJ, Hess P, Flavell RA and Davis RJ. (2003). Mol. Cell, 11, 1479-1489.
35. Lau LF and Nathans D. (1985). EMBO J., 4, 3145-3151.
36. Lei K and Davis RJ. (2003). Proc. Natl. Acad. Sci. USA, 100, 2432-2437.
37. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D and Davis RJ. (2002). Mol. Cell. Biol., 22, 4929-4942.
38. Li CH, Hu YH, Mayr M and Xu QB. (1999). J. Biol. Chem., 274, 25273-25280.
39. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM and Liu YS. (2001). Mol. Cell. Biol., 21, 8213-8224.
40. Liu YS, Gorospe M, Yang CL and Holbrook NJ. (1995). J. Biol. Chem., 270, 8377-8380.
41. MacLaren A, Black EJ, Clark W and Gillespie DAF. (2004). Mol. Cell. Biol., 24, 9006-9018.
42. Martindale JL and Holbrook NJ. (2002). J. Cell. Physiol., 192, 1-15.
43. Mashima T, Udagawa S and Tsuruo T. (2001). J. Cell. Physiol, 188, 352-358.
44. Mckay BC, Becerril C and Ljungman M. (2001). Oncogene, 20, 6805-6808.
45. Mckay BC, Ljungman M and Rainbow AJ. (1998). Oncogene, 17, 545-555.
46. Mercurio F and Manning AM. (1999). Oncogene, 18, 6163-6171.
47. Mitchell JR, Hoeijmakers JHJ and Niedernhofer LJ. (2003). Curr. Opin. Cell Biol., 15, 232-240.
48. Mizuno R, Oya M, Shiomi T, Marumo K, Okada Y and Murai M. (2004). J. Urol., 172, 723-727.
49. Morrison DK and Davis RJ. (2003). Ann. Rev. Cell Dev. Biol., 19, 91-118.
50. Nakajima S, Lan L, Kanno S, Takao M, Yamamoto K, Eker APM and Yasui A. (2004). J. Biol. Chem., 279, 46674-46677.
51. Nateri AS, Riera-Sans L, Da Costa C and Behrens A. (2004). Science, 303, 1374-1378.
52. Queille S, Drougard C, Sarasin A and Daya-Grosjean L. (2001). J. Invest. Dermatol., 117, 1162-1170.
53. Rockx DAP, Mason R, van Hoffen A, Barton MC, Citterio E, Bregman DB, van Zeeland AA, Vrieling H and Mullenders LHF. (2000). Proc. Natl. Acad. Sci. USA, 97, 10503-10508.
54. Rosette C and Karin M. (1996). Science, 274, 1194-1197.
55. Sachsenmaier C, Radlerpohl A, Zinck R, Nordheim A, Herrlich P and Rahmsdorf HJ. (1994). Cell, 78, 963-972.
56. Sanchez-Perez I, Martinez-Gomariz M, Williams D, Keyse SM and Perona R. (2000). Oncogene, 19, 5142-5152.
57. Sanchez-Perez I, Murguia JR and Perona R. (1998). Oncogene, 16, 533-540.
58. Schreiber M, Baumann B, Cotten M, Angel P and Wagner EF. (1995). EMBO J., 14, 5338-5349.
59. Shaulian E and Karin M. (2001). Oncogene, 20, 2390-2400.
60. Shaulian E and Karin M. (2002). Nat. Cell Biol., 4, E131-E136.
61. Slack DN, Seternes OM, Gabrielsen M and Keyse SM. (2001). J. Biol. Chem., 276, 16491-16500.
62. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace AJ. (2000). Mol. Cell. Biol., 20, 3705-3714.
63. Spivak G, Itoh T, Matsunaga T, Nikaido O, Hanawalt P and Yamaizumi M. (2002). DNA Repair, 1, 629-643.
64. Svejstrup JQ. (2002). Mol. Cell, 9, 1151-1152.
65. Todd DE, Densham RM, Molton SA, Balmanno K, Newson C, Weston CR, Garner AP, Scott L and Cook SJ. (2004). Oncogene, 23, 3284-3295.
66. van Dam H and Castellazzi M. (2001). Oncogene, 20, 2453-2464.
67. van Dam H, Duyndam M, Rottier R, Bosch A, De Vries-Smits L, Herrlich P, Zantema A, Angel P and van der Eb AJ. (1993). EMBO J., 12, 479-487.
68. van Dam H, Offringa R, Meijer I, Stein B, Smits AM, Herrlich P, Bos JL and van der Eb AJ. (1990). Mol. Cell. Biol., 10, 5857-5864.
69. van Dam H, Offringa R, Smits AMM, Bos JL, Jones NC and van der Eb AJ. (1989). Oncogene, 4, 1207-1212.
70. van Oosten M, Rebel H, Friedberg EC, van Steeg H, van der Horst GTJ, van Kranen HJ, Westerman A, van Zeeland AA, Mullenders LHF and de Gruijl FR. (2000). Proc. Natl. Acad. Sci. USA, 91, 11268-11273.
71. van Steeg H and Kraemer KH. (1999). Mol. Med. Today, 5, 86-94.
72. Wada T, Joza N, Cheng HYM, Sasaki T, Kozieradzki I, Bachmaier K, Katada T, Schreiber M, Wagner EF, Nishina H and Penninger JM. (2004). Nat. Cell Biol., 6, 215-226.
73. Weston CR and Davis RJ. (2002). Curr. Opin. Genet Dev., 12, 14-21.
74. Xu QH, Konta T, Nakayama KJ, Furusu A, Moreno-Manzano V, Lucio-Cazana J, Ishikawa Y, Fine LG, Yao J and Kitamura M. (2004). Free Radic Biol. Med., 36, 985-993.
75. Yan CH, Wang H and Boyd DD. (2002). J. Biol. Chem., 277, 10804-10812.